BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 12447395)

  • 21. Microcell mediated chromosome transfer maps the Fanconi anaemia group D gene to chromosome 3p.
    Whitney M; Thayer M; Reifsteck C; Olson S; Smith L; Jakobs PM; Leach R; Naylor S; Joenje H; Grompe M
    Nat Genet; 1995 Nov; 11(3):341-3. PubMed ID: 7581463
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of the Fanconi anemia/BRCA pathway and recombination repair in the cellular response to solar ultraviolet light.
    Dunn J; Potter M; Rees A; RĂ¼nger TM
    Cancer Res; 2006 Dec; 66(23):11140-7. PubMed ID: 17145857
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fanconi's anemia cell lines show distinct mechanisms of cell death in response to mitomycin C or agonistic anti-Fas antibodies.
    Clarke AA; Gibson FM; Scott J; Myatt N; Rutherford TR
    Haematologica; 2004 Jan; 89(1):11-20. PubMed ID: 14754601
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FANCD2: a branch-point in DNA damage response?
    Grompe M
    Nat Med; 2002 Jun; 8(6):555-6. PubMed ID: 12042798
    [No Abstract]   [Full Text] [Related]  

  • 25. The Fanconi anaemia/BRCA pathway.
    D'Andrea AD; Grompe M
    Nat Rev Cancer; 2003 Jan; 3(1):23-34. PubMed ID: 12509764
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Chinese hamster FANCG/XRCC9 mutant NM3 fails to express the monoubiquitinated form of the FANCD2 protein, is hypersensitive to a range of DNA damaging agents and exhibits a normal level of spontaneous sister chromatid exchange.
    Wilson JB; Johnson MA; Stuckert AP; Trueman KL; May S; Bryant PE; Meyn RE; D'Andrea AD; Jones NJ
    Carcinogenesis; 2001 Dec; 22(12):1939-46. PubMed ID: 11751423
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The BRCA1-interacting helicase BRIP1 is deficient in Fanconi anemia.
    Levran O; Attwooll C; Henry RT; Milton KL; Neveling K; Rio P; Batish SD; Kalb R; Velleuer E; Barral S; Ott J; Petrini J; Schindler D; Hanenberg H; Auerbach AD
    Nat Genet; 2005 Sep; 37(9):931-3. PubMed ID: 16116424
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current knowledge on the pathophysiology of Fanconi anemia: from genes to phenotypes.
    Yamashita T; Nakahata T
    Int J Hematol; 2001 Jul; 74(1):33-41. PubMed ID: 11530803
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The 4N cell cycle delay in Fanconi anemia reflects growth arrest in late S phase.
    Akkari YM; Bateman RL; Reifsteck CA; D'Andrea AD; Olson SB; Grompe M
    Mol Genet Metab; 2001 Dec; 74(4):403-12. PubMed ID: 11749045
    [TBL] [Abstract][Full Text] [Related]  

  • 30. "Dub"bing a tumor suppressor pathway.
    Niedzwiedz W; Patel KJ
    Cancer Cell; 2005 Feb; 7(2):114-5. PubMed ID: 15710323
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnosis of Fanconi Anaemia by ionising radiation- or mitomycin C-induced micronuclei.
    Francies FZ; Wainwright R; Poole J; De Leeneer K; Coene I; Wieme G; Poirel HA; Brichard B; Vermeulen S; Vral A; Slabbert J; Claes K; Baeyens A
    DNA Repair (Amst); 2018 Jan; 61():17-24. PubMed ID: 29154021
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Positional cloning of the gene for Nijmegen breakage syndrome.
    Matsuura S; Tauchi H; Nakamura A; Kondo N; Sakamoto S; Endo S; Smeets D; Solder B; Belohradsky BH; Der Kaloustian VM; Oshimura M; Isomura M; Nakamura Y; Komatsu K
    Nat Genet; 1998 Jun; 19(2):179-81. PubMed ID: 9620777
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FANCD2 binds CtIP and regulates DNA-end resection during DNA interstrand crosslink repair.
    Unno J; Itaya A; Taoka M; Sato K; Tomida J; Sakai W; Sugasawa K; Ishiai M; Ikura T; Isobe T; Kurumizaka H; Takata M
    Cell Rep; 2014 May; 7(4):1039-47. PubMed ID: 24794430
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The DNA crosslink-induced S-phase checkpoint depends on ATR-CHK1 and ATR-NBS1-FANCD2 pathways.
    Pichierri P; Rosselli F
    EMBO J; 2004 Mar; 23(5):1178-87. PubMed ID: 14988723
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway.
    Garcia-Higuera I; Taniguchi T; Ganesan S; Meyn MS; Timmers C; Hejna J; Grompe M; D'Andrea AD
    Mol Cell; 2001 Feb; 7(2):249-62. PubMed ID: 11239454
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Somatic mosaicism in Fanconi anemia: molecular basis and clinical significance.
    Lo Ten Foe JR; Kwee ML; Rooimans MA; Oostra AB; Veerman AJ; van Weel M; Pauli RM; Shahidi NT; Dokal I; Roberts I; Altay C; Gluckman E; Gibson RA; Mathew CG; Arwert F; Joenje H
    Eur J Hum Genet; 1997; 5(3):137-48. PubMed ID: 9272737
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of the Fanconi anemia polypeptide, FAC, upon p53 induction and G2 checkpoint regulation.
    Kupfer GM; D'Andrea AD
    Blood; 1996 Aug; 88(3):1019-25. PubMed ID: 8704210
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulated interaction of the Fanconi anemia protein, FANCD2, with chromatin.
    Montes de Oca R; Andreassen PR; Margossian SP; Gregory RC; Taniguchi T; Wang X; Houghtaling S; Grompe M; D'Andrea AD
    Blood; 2005 Feb; 105(3):1003-9. PubMed ID: 15454491
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ATR couples FANCD2 monoubiquitination to the DNA-damage response.
    Andreassen PR; D'Andrea AD; Taniguchi T
    Genes Dev; 2004 Aug; 18(16):1958-63. PubMed ID: 15314022
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of cell cycle checkpoint responses after ionizing radiation in Nijmegen breakage syndrome cells.
    Yamazaki V; Wegner RD; Kirchgessner CU
    Cancer Res; 1998 Jun; 58(11):2316-22. PubMed ID: 9622065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.